Official data from INPI

122021007292

ArquivadaUtility ModelPCT · US2016026269

Talk to an expert

Application data

Number

122021007292

Type

Utility Model

Filing

04/06/2016

Publication

PCT

US2016026269

View on INPI

Progress at the INPI

Filing04/06/16
Publication
Abandoned
Allowance
Grant
In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/18/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ACCELERON PHARMA INC.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

03/18/2025

RPI 2828

Exigência - art. 36 da LPI

#6.1

12/03/2024

RPI 2813

Notificação de pedido dividido

#2.4

05/04/2021

RPI 2626

Requerimento de pedido de patente

#2.10

Número de Protocolo '870210034753' em 16/04/2021 14:17 (WB)

04/27/2021

RPI 2625

From the same holder

PROTEÍNAS ACTRII E USOS DAS MESMAS PROTEÍNAS ACTRII E USOS DAS MESMAS ANTAGONISTAS DE ACTRII-ALK4 E MÉTODOS PARA TRATAR INSUFICIÊNCIA CARDÍACA ANTAGONISTAS DE ACTRII-ALK4 E MÉTODOS PARA TRATAR INSUFICIÊNCIA CARDÍACA PROTEÍNAS ACTRII PARA TRATAMENTO DE HIPERTENSÃO ARTERIAL PULMONAR (PAH)ANTAGONISTAS DE ACTRII-ALK4 E MÉTODOS DE TRATAMENTO DE INSUFICIÊNCIA CARDÍACA PROTEÍNAS ACTRII E USO NO TRATAMENTO DA HIPERTENSÃO PULMONAR PÓS-CAPILAR HETEROMULTÍMEROS ACTRIIA E ACTRIIB DE BRAÇO ÚNICO E MÉTODOS PARA TRATAR DOENÇAS OU CONDIÇÕES RENAIS

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.